Telomir Pharmaceuticals, Inc. (TELO)

CIK 1971532 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Telomir Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Nov 6, 202610-Q0001493152-26-050489
Nov 5, 2026424B30001493152-26-050252
Nov 5, 2026EFFECT9999999995-26-003455
Oct 27, 2026S-30001493152-26-048714
Oct 6, 20268-K0001493152-26-045860
Sep 17, 20268-K0001493152-26-043053
Sep 16, 20268-K0001493152-26-042926
Sep 14, 20268-K0001493152-26-042483
Aug 19, 2026DEFA14A0001493152-26-039116
Aug 14, 2026SCHEDULE 13G/A0001104659-26-097283
Aug 13, 202610-Q0001493152-26-037854
Aug 10, 20268-K0001493152-26-036742
Jul 28, 2026DEF 14A0001493152-26-035026
Jul 27, 202640001493152-26-034813
Jul 27, 202640001493152-26-034811
Jul 27, 202640001493152-26-034812
Jun 15, 20268-K0001493152-26-028614
Jun 9, 202630001493152-26-027958
Jun 8, 20268-K0001493152-26-027752
May 22, 202640001493152-26-025115
May 22, 202640001493152-26-025113
May 22, 202640001493152-26-025116
May 22, 202640001493152-26-025114
May 20, 20268-K0001493152-26-024517
May 14, 202610-Q0001493152-26-023010